Cargando…

Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life

OBJECTIVE: To determine costs of hospitalization associated with bronchopulmonary dysplasia (BPD) during the first year in very low birth weight infants. STUDY DESIGN: Retrospective cohort study of California births from 2008 to 2011 linking birth certificate, discharge records, and clinical data fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lapcharoensap, Wannasiri, Bennett, Mihoko V., Xu, Xiao, Lee, Henry C., Dukhovny, Dmitry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920537/
https://www.ncbi.nlm.nih.gov/pubmed/31700090
http://dx.doi.org/10.1038/s41372-019-0548-x
_version_ 1783480975080030208
author Lapcharoensap, Wannasiri
Bennett, Mihoko V.
Xu, Xiao
Lee, Henry C.
Dukhovny, Dmitry
author_facet Lapcharoensap, Wannasiri
Bennett, Mihoko V.
Xu, Xiao
Lee, Henry C.
Dukhovny, Dmitry
author_sort Lapcharoensap, Wannasiri
collection PubMed
description OBJECTIVE: To determine costs of hospitalization associated with bronchopulmonary dysplasia (BPD) during the first year in very low birth weight infants. STUDY DESIGN: Retrospective cohort study of California births from 2008 to 2011 linking birth certificate, discharge records, and clinical data from California Perinatal Quality Care Collaborative. Inclusion: birth weight 401–1500 g, gestational age < 30 weeks, inborn or transferred within 2 days, alive at 36 weeks corrected, and without major congenital anomalies. Outcomes included cost and length of stay of initial hospitalization and rehospitalizations. RESULT: Out of 7998 eligible infants, 2696 (33.7%) developed BPD. Median hospitalization cost in the first year was $377,871 per infant with BPD compared with $175,836 per infant without BPD (adjusted cost ratio 1.54, 95% confidence interval (CI) 1.49–1.59). Infants with BPD also had longer length of stay and a higher likelihood of rehospitalization. CONCLUSION: BPD is associated with substantial resource utilization. Prevention strategies could help conserve healthcare resources.
format Online
Article
Text
id pubmed-6920537
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group US
record_format MEDLINE/PubMed
spelling pubmed-69205372020-05-07 Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life Lapcharoensap, Wannasiri Bennett, Mihoko V. Xu, Xiao Lee, Henry C. Dukhovny, Dmitry J Perinatol Article OBJECTIVE: To determine costs of hospitalization associated with bronchopulmonary dysplasia (BPD) during the first year in very low birth weight infants. STUDY DESIGN: Retrospective cohort study of California births from 2008 to 2011 linking birth certificate, discharge records, and clinical data from California Perinatal Quality Care Collaborative. Inclusion: birth weight 401–1500 g, gestational age < 30 weeks, inborn or transferred within 2 days, alive at 36 weeks corrected, and without major congenital anomalies. Outcomes included cost and length of stay of initial hospitalization and rehospitalizations. RESULT: Out of 7998 eligible infants, 2696 (33.7%) developed BPD. Median hospitalization cost in the first year was $377,871 per infant with BPD compared with $175,836 per infant without BPD (adjusted cost ratio 1.54, 95% confidence interval (CI) 1.49–1.59). Infants with BPD also had longer length of stay and a higher likelihood of rehospitalization. CONCLUSION: BPD is associated with substantial resource utilization. Prevention strategies could help conserve healthcare resources. Nature Publishing Group US 2019-11-07 2020 /pmc/articles/PMC6920537/ /pubmed/31700090 http://dx.doi.org/10.1038/s41372-019-0548-x Text en © The Author(s), under exclusive licence to Springer Nature America, Inc. 2019 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Lapcharoensap, Wannasiri
Bennett, Mihoko V.
Xu, Xiao
Lee, Henry C.
Dukhovny, Dmitry
Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life
title Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life
title_full Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life
title_fullStr Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life
title_full_unstemmed Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life
title_short Hospitalization costs associated with bronchopulmonary dysplasia in the first year of life
title_sort hospitalization costs associated with bronchopulmonary dysplasia in the first year of life
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6920537/
https://www.ncbi.nlm.nih.gov/pubmed/31700090
http://dx.doi.org/10.1038/s41372-019-0548-x
work_keys_str_mv AT lapcharoensapwannasiri hospitalizationcostsassociatedwithbronchopulmonarydysplasiainthefirstyearoflife
AT bennettmihokov hospitalizationcostsassociatedwithbronchopulmonarydysplasiainthefirstyearoflife
AT xuxiao hospitalizationcostsassociatedwithbronchopulmonarydysplasiainthefirstyearoflife
AT leehenryc hospitalizationcostsassociatedwithbronchopulmonarydysplasiainthefirstyearoflife
AT dukhovnydmitry hospitalizationcostsassociatedwithbronchopulmonarydysplasiainthefirstyearoflife